Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 33 Show results per page	View Search Criteria \| Help With Results


1.		STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Completed				18 and over				Pharmaceutical / Industry				CSMS995AUS38 STOP Trial, NCT00050635

Last Modified: 9/1/1995


2.		Phase III Randomized Double-Blind Study of SSTN LAR Given Every 4 Weeks vs Open-Label Standard SSTN Given TID for Symptomatic Control of Malignant Carcinoid Syndrome (Summary Last Modified 09/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				18 and over				Pharmaceutical / Industry				MSKCC-94133A1 NCI-V95-0664

Last Modified: 6/20/2008 First Published: 11/1/1996


3.		Phase III Randomized Study of Adjuvant Therapy with Tamoxifen Alone vs Tamoxifen plus Octreotide in Previously Treated Postmenopausal Women with Stage I/II/III Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				postmenopausal				Other				CAN-NCIC-MA14 NCI-V96-1060, NCT00002864, MA14

Last Modified: 5/14/2007 First Published: 8/1/1997


4.		Phase III Randomized Trial of Octreotide Acetate vs Conventional Therapy With Loperamide Hydrochloride for Chemotherapy Related Diarrhea in Patients With Colorectal Cancer (Summary Last Modified 08/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				E-E1295 CLB-9770, SWOG-E1295, NCI-P97-0081, NCT00003057

Last Modified: 3/1/2001 First Published: 9/1/2000


5.		Phase III Randomized Study of Octreotide in the Prevention of Diarrhea Induced By Irinotecan in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				18 and over				Pharmaceutical / Industry				NOVARTIS-CSMS995US05 NCT00006269

Last Modified: 9/10/2008 First Published: 4/1/2002


6.		Phase III Randomized Study of Octreotide For Prevention of Acute Diarrhea in Patients Receiving Radiotherapy to the Pelvis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				NCCTG-N00CA NCI-P02-0221, N00CA, NCT00033605

Last Modified: 8/1/1990


7.		Phase III Randomized Double-blind Comparison of Therapy with the Somatostatin Analogue Sandostatin vs Placebo in Patients with Metastatic or Locally Unresectable Colorectal Cancer Who Are without Significant Symptoms (Summary Last Modified 08/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				NCCTG-874652 MAYO-874652, NCCTG-87-46-52

Last Modified: 5/15/2007


8.		Phase III Study of Somatostatin Analog vs Placebo for Inhibition of Postoperative Pancreatic Drainage in Patients Who Have Undergone Excision of Pancreatic Islet Cell Tumors (Summary Last Modified 04/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				any age				NCI				NCI-89-C-80 NCI-T89-0090N, T89-0090

Last Modified: 9/1/1994


9.		Phase III Comparison of TMX vs Sandostatin/TMX in Patients with Metastatic or Recurrent Breast Cancer (Summary Last Modified 09/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				postmenopausal				NCI				NCCTG-893253 MAYO-893253, MCGILL-ET-9110, NCCTG-89-32-53

Last Modified: 6/1/1997


10.		Phase III Comparison of Octreotide vs 5-FU vs 5-FU/CF in the Treatment of Advanced Adenocarcinoma of the Pancreas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				over 18				NCI				NCCTG-894352 MAYO-894352, NCCTG-89-43-52

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute